Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - OTHER LONG-TERM ASSETS
Other Long-term Assets TVTX - Travere Therapeutics, Inc.
53.8 M
LAST VALUE
120.58%
2 YEAR CAGR
29.62%
5 YEAR CAGR
39.50%
10 YEAR CAGR